drugset / Trial / NCT03404570

Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

NCT03404570

Phase 2 Completed 60 enrolled Atacama Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a pilot exploratory study to evaluate the safety and efficacy of TC-5214 in subjects with palmar hyperhidrosis.

Timeline

Start
2017-12-21
Primary completion
2019-01-18
Completion
2019-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject dexmecamylamine Other / unclassified 2 mg Oral
Subject dexmecamylamine Other / unclassified 4 mg Oral